Chair Yoga for Stress in Dementia

Sponsor
Lady Davis Institute (Other)
Overall Status
Suspended
CT.gov ID
NCT04162964
Collaborator
(none)
40
2
23.2
20
0.9

Study Details

Study Description

Brief Summary

Dementia is widely prevalent and results in high direct and indirect health costs. Dementia is associated with stress, anxiety, and depression in both patients and caregivers, and caregiver burden is extremely common. Treatment protocols for patients and caregivers are unclear and insufficient; drug treatments to manage behavioural and psychological symptoms of dementia can yield serious negative side effects, and caregivers may not have access to one-on-one psychotherapy due to high costs and long wait times. Yoga is an ancient Indian mind-body practice that uses physical postures, breathing exercises, and meditation. Yoga may be a viable therapeutic modality to address the psychological challenges associated with dementia in patients and caregivers, as it has been shown to decrease stress and improve anxiety and depressive symptoms in various populations. Recent research has suggested that patients with dementia and their caregivers may also experience positive effects on their mental health from practicing yoga. Furthermore, when yoga is taught in a gentle and mindful manner, it is generally not associated with any negative side effects. While there is preliminary data on dyadic exercise interventions for dementia patients and their caregivers, to date no research has examined the effectiveness of a dyadic yoga intervention on stress, anxiety, and depression.

The investigators propose an 8-week study of a dyadic chair yoga program for patients with mild to moderate dementia and their caregivers (n = 30-40 participants). Our primary outcome of interest is changes in perceived stress, while secondary outcomes include changes in symptoms of depression and anxiety. The investigators will also look at the effects of the chair yoga program on caregiver burden, quality of interactions, well-being, mindfulness, and self-compassion. All outcomes will be assessed before the program starts and upon its termination. Participants will attend a 1-hour weekly group yoga class (4-10 participants per group) with their dyad for 8-weeks, and will also be given a video recording of a yoga class to practice together at home as often as possible. The investigators hypothesize that after the 8 week yoga program, patients and caregivers will report lower stress, as well as reduced symptoms of anxiety and depression. Results will be available mid-2020.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Chair Yoga
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effectiveness of a Dyadic Chair Yoga Intervention for Reducing Stress in Patients With Dementia and Their Caregivers
Actual Study Start Date :
Jan 27, 2020
Anticipated Primary Completion Date :
Jan 1, 2021
Anticipated Study Completion Date :
Jan 1, 2022

Outcome Measures

Primary Outcome Measures

  1. Changes in perceived stress scores as measured by the Perceived Stress Scale (PSS) [Baseline, 8-weeks]

    Using an 8-week single arm pilot trial, assess the effects of chair yoga on perceived stress in patients and caregivers, using the PSS. Scores on the PSS can range from 0-40, with higher scores indicating higher perceived stress Hypothesis: Following participation in an 8-week gentle chair yoga program, patients with dementia and their caregivers will report lower perceived stress, as measured by the Perceived Stress Scale (PSS)

Secondary Outcome Measures

  1. Changes in depressive symptoms as measured by the Patient Health Questionnaire (PHQ-9) [Baseline, 8-weeks]

    Using an 8-week single arm pilot trial, assess the effects of chair yoga on patient and caregiver depressive symptoms using the PHQ-9. Scores on the PHQ-9 can range from 0-27, with higher scores indicating more severe depression. Hypothesis: Patients with dementia and their caregivers will report less severe symptoms of depression, as measured by the full version of the Patient Health Questionnaire (PHQ-9), following participation in an 8-week gentle chair yoga program.

  2. Changes in symptoms of anxiety as measured by the Generalized Anxiety Disorder 7-item scale (GAD-7) [Baseline, 8-weeks]

    Using an 8-week single arm pilot trial, assess the effects of chair yoga on symptoms of anxiety in patients and caregivers using the GAD-7. Scores on the GAD-7 range from 0-21, with higher scores indicating more severe anxiety. Hypothesis: Patients with dementia and/or their caregivers will report fewer symptoms of anxiety, as measured by the Generalized Anxiety Disorder 7-Item Scale (GAD-7), following participation in an 8-week gentle chair yoga program.

Other Outcome Measures

  1. Changes in caregiver burden as measured by the Zarit Burden Inventory (ZBI) [Baseline, 8-weeks]

    Assess the effects of chair yoga on caregiver burden using the ZBI following 8 weeks of chair yoga. Scores on the ZBI can range from 0-88, with higher scores corresponding to higher levels of burden. Hypothesis 1: Caregivers of patients with dementia will report lower caregiver burden, as measured by the Zarit Burden Scale (ZBI), following participation in an 8-week gentle chair yoga program. Hypothesis 2: Lower patient scores on the PHQ-9 and GAD-7 (week 8) will be associated with decreased caregiver burden following participation in an 8-week gentle chair yoga program.

  2. Changes in relationship closeness as measured by the Whitlatch Relationship Closeness Scale [Baseline, 8-weeks]

    Assess the effects of chair yoga on levels of caregiver-rated relationship closeness using the Whitlatch Relationship Closeness Scale. Scores on the Whitlatch Relationship Closeness Scale range from 0-24, with higher scores indicating closer relationships.

  3. Changes in well-being as measured by the 12-Item Well-Being Questionnaire (W-BQ12) [Baseline, 8-weeks]

    Assess the effects of 8-weeks of chair yoga on patient and caregiver well-being using the W-BQ12. Scores on the W-BQ12 range from 0-72, with higher scores indicating a greater sense of well-being.

  4. Changes in levels of mindfulness as measured by the Five Facet Mindfulness Questionnaire (FFMQ-short form) [Baseline, 8-weeks]

    Assess the effects of 8 weeks of chair yoga on patient and caregiver levels of mindfulness using the short form of the FFMQ. Scores on the short-form of the Five Facet Mindfulness Scale range from 0-120, with higher scores indicating higher levels of mindfulness.

  5. Changes in levels of self-compassion as measured by the Self-Compassion Scale (SCS-short form) [Baseline, 8-weeks]

    Assess the effects of 8 weeks of chair yoga on patient and caregiver levels of self-compassion using the short form of the SCS. Scores on the short for of the SCS range from 0-60, with higher scores indicating higher levels of self-compassion.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients will have mild cognitive impairment or mild to moderate dementia (MMSE score between 10-26 inclusive) OR a diagnosis from his/her clinician of mild cognitive impairment or mild to moderate dementia

  • Patient and caregiver have contact at least 3 times per week

  • Either patient and/or caregiver will have a score of at least 10 on the PSS

  • Sufficient hearing to follow verbal instructions

  • Able to sit for 45 minutes without discomfort

Exclusion Criteria:
  • Patients will not have severe dementia (MMSE score < 10 OR diagnosis from his/her clinician)

  • Caregivers will not have dementia (MMSE score < 24)

  • Acute psychotic symptoms

  • Acute suicidal ideation or intent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institute of Community and Family Psychiatry Montreal Quebec Canada H3T 1E4
2 Douglas Mental Health University Institute Montreal Quebec Canada H4H 1R3

Sponsors and Collaborators

  • Lady Davis Institute

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Soham Rej MD, MSc, Principal Investigator, Lady Davis Institute
ClinicalTrials.gov Identifier:
NCT04162964
Other Study ID Numbers:
  • GeriPARTy
First Posted:
Nov 14, 2019
Last Update Posted:
Sep 10, 2020
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Soham Rej MD, MSc, Principal Investigator, Lady Davis Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 10, 2020